Todd Brady | President & Chief Executive Officer |
Joshua Reed | Chief Financial Officer |
David McMullin | Chief Commercial Officer |
Louise Chen | Cantor |
Yigal Nochomovit | Citi Group |
Adam Walsh | Stifel |
Esther Hong | Janney |
I-Eh Jen | Laidlaw |
Matthew Cross | Jones Trading |
Good morning and to welcome to the Aldeyra Therapeutics Full Year 2019 Financial Results Conference Call.
At this time, I would like to turn the call over to Mr. Joshua Reed, the Company's Chief Financial Officer. Please go ahead, sir.
Thank you and good morning, everyone.